FGF-2 antagonist (Praecis)

N/A

Report date: 2025/03/20 20:00:06
NME

Base Information

Drug NameFGF-2 antagonist (Praecis)
Drug Alias Namebasic fibroblast growth factor antagonist (Praecis)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionFibroblast growth factor 2 inhibitors
TargetsFibroblast growth factor 2
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesPraecis Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesPraecis Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsProstatic Neoplasms

Other Information

ATC CodeN/A
Related LinksN/A